Lung Large Cell Neuroendocrine Carcinoma

Lung Large Cell Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 40%
Top sponsor: Technische Universität Dresden
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04010357	Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC	completed	Phase 2	14	Case Comprehensive Cancer CenterOTHER	1	May 12, 2026	clinicaltrials

Data updated 23 days agoSource updated May 12, 2026source: clinicaltrials